PharmaControl Corp said acquired Private Formulations Inc & lt ; Revco D.S .
Inc > six mln dlrs cash , 13,550,000 dlr promissory note warrant buy 200,000 PharmaControl common share .
PharmaControl said purchase price financed , along one mln dlrs working capital , secured institutional financing .
The company said betweenm 11,550,000 dlrs 12,550,000 dlrs f principal amount Revco note , plus accrued interest , payable June 30 .
The balance payable three year .
PharmaControl said expects make payment due Revco proceeds proposed offering unit consisting convertible subordinated debenturers common stock currently file Securities Exchange Commission .
Upon closing public offering , company said , expects secured institutional financing increase total 12 mln dlrs .
Private Formulations primarily engaged manufacture distribution vitamin private label over-the-counter pharmaceutical product .
Reuter & # 3 ; 